desloratadine has been researched along with Cancer of Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, YL; Guan, XY; He, Y; Li, B; Li, ZQ; Liao, HX; Qin, DJ; Tan, XP; Wei, X; Yang, J; Zhang, GG; Zhu, YD | 1 |
1 other study(ies) available for desloratadine and Cancer of Liver
| Article | Year |
|---|---|
Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Myristic Acid; Protein Processing, Post-Translational | 2023 |